# Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

> **NCT00223145** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Abdenour Nabid** · enrollment: 600 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Radiotherapy 70 Gy
- **RADIATION:** Radiotherapy 76 Gy
- **DRUG:** Androgen blockade

## Key facts

- **NCT ID:** NCT00223145
- **Lead sponsor:** Abdenour Nabid
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2000-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2025-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00223145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00223145, "Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00223145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*